España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Core One Labs
CLABF
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.0654
0.00045
0.69%
At close: -
$0.0600
-0.00545
-8.33%
After Hours: Jan 31, 8:56 AM EDT
Get Report
Comment
Core One Labs (CLABF) Forecast
News
Earnings
Core One Labs (CLABF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Core One Labs (OTC:CLABF) Stock
Core One Labs Stock (OTC: CLABF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 24, 2023
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Lara Goldstein
Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds
Vuk Zdinjak
Monday, May 08, 2023
Core One In Talks With Multiple Companies To Supply Psilocybin
Vuk Zdinjak
Monday, April 24, 2023
Core One's Awakened Lays The Groundwork For The Large-Scale Production Of Psychedelic Compounds With Synthetic Production Of Psilocin
Vuk Zdinjak
Thursday, January 26, 2023
Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin
Lara Goldstein
Wednesday, January 25, 2023
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Lara Goldstein
Saturday, January 21, 2023
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
Lara Goldstein
Wednesday, December 28, 2022
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
Lara Goldstein
Wednesday, December 21, 2022
Psychedelic Mushrooms Soon To Be Commercially Produced And Sold In Canada
Lara Goldstein
Monday, September 26, 2022
Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products
Lara Goldstein
Friday, September 02, 2022
New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials
Lara Goldstein
Wednesday, April 06, 2022
Core One Labs Begins Trading On OTCQB
Fermin Orgambide
Monday, December 27, 2021
Psychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition
Natan Ponieman
Monday, October 18, 2021
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman
Wednesday, October 13, 2021
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman
Monday, August 23, 2021
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
Natan Ponieman
Monday, May 10, 2021
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
Natan Ponieman
Monday, May 03, 2021
Stocks to Buy for the "Summer of New York"
Gregory Bergman - CapitalWatch
Monday, April 26, 2021
Psyched: MindMed and Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Gets Back To Trading
Natan Ponieman
Monday, April 12, 2021
Psyched: Entheon Launches Psychedelics Genetic Test, Mydecine Unveils Psychedelic Drug Candidates, California Bill Passes Senate Committee
Natan Ponieman
Tuesday, April 06, 2021
Psyched: MindMed's 2020 Financials, Psychedelics ETF Rebalancing, Country's First Psychedelics Masters Degree
Natan Ponieman
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
The Cannabis Investor
Friday, January 01, 2021
Psyched: The First Psychedelics ETF, Beckley Raises $19M, 3 Companies Go Public
Natan Ponieman
Friday, January 03, 2020
The Week In Cannabis: Illinois Goes Rec, Quebec Pulls Back And A Recap Of 2019
Javier Hasse
Core One Labs Subsidiary Completes Harvests Of Top Grade Flower At Adelanto Indoor Grow
Nina Zdinjak
Monday, December 09, 2019
Core One Labs Subsidiary Enters Into Project With Reiziger Holland To Boost Harvest Yields
Nina Zdinjak
Sunday, December 08, 2019
The Week In Cannabis: Brazil Regulates Sales, Michigan Starts Adult Sales, Lil Wayne Goes Green, Federal Agencies Move Forward
Javier Hasse
Thursday, December 05, 2019
Core One Labs Posts Q3 Net Loss, Signs LOI For Cultivation Contract With Golden State Banana
Nina Zdinjak
Monday, November 04, 2019
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
Friday, October 18, 2019
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
Wednesday, October 09, 2019
Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin
